Dr. Ravi Teja Pasam, MD

Dr. Pasam practices at Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham.

Dr. Pasam's NPI, 1073900312, was assigned on April 24, 2015. Dr. Pasam holds New Hampshire license 22497.

Dr. Pasam's primary practice is Wentworth-Douglass Hospital, at 789 Central Ave, Dover, NH 03820 in Strafford County. The practice phone is (603) 740-2580.

Dr. Pasam's primary practice is Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham. Dr. Pasam is also affiliated with Portsmouth Regional Hospital. The medical group on file is Wentworth-Douglass Hospital. Dmand AI also links Dr. Pasam to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pasam practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Pasam's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Pasam is board certified in internal medicine by the American Board of Internal Medicine. Dr. Pasam is licensed in New Hampshire.

CMS data shows 972 Medicare services from Dr. Pasam across 6 procedure codes in 2024, for 389 Medicare patients. Medicare paid $68,326 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 389 Medicare patients who saw Dr. Pasam in 2024. The largest group is 75 to 84, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pasam's median patient age at 73, with 56% women.

In 2024, Dr. Pasam wrote 387 Medicare Part D claims for 181 patients. 91% of them were for generic drugs. CMS names the drug for 162 of them, across 9 drugs with 11 or more claims each, at $896 in total drug cost. In 2023, CMS named 77 claims across 4 drugs.

Dr. Pasam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Pasam from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $114.